Spanish Drug Regulator Probes Death of Woman Vaccinated With AstraZeneca

© AP Photo / Natacha PisarenkoIn this Aug. 14, 2020, file photo, laboratory technicians work at the mAbxience biopharmaceutical company on an experimental coronavirus vaccine developed by Oxford University and the laboratory AstraZeneca in Garin, Argentina.
In this Aug. 14, 2020, file photo, laboratory technicians work at the mAbxience biopharmaceutical company on an experimental coronavirus vaccine developed by Oxford University and the laboratory AstraZeneca in Garin, Argentina. - Sputnik International, 1920, 17.03.2021
Subscribe
US
India
Global
MOSCOW (Sputnik) - The Spanish medicines agency is looking into the death of a woman who suffered a brain bleed caused by a blood clot days after getting an AstraZeneca shot, the Health Ministry said Wednesday.

"AEMPS, other regulators and the European medicines agency EMA are gathering data and conducting a thorough investigation to determine whether, in addition to a temporal connection to the administration of the vaccine, there was a possible causative relationship", a statement read.

The 43-year-old received the first dose of the AstraZeneca vaccine on 3 March and reported a headache within hours, which was dismissed as a common side effect. She sought medical help 10 days later after her symptoms worsened. The surgery revealed a brain bleed and swelling. She died on Monday.

© AFP 2022 / ORLANDO SIERRAA nurse prepares an AstraZeneca vaccine against COVID-19 at the Alonso Suazo healthcare center in Tegucigalpa, on March 15, 2021.
Spanish Drug Regulator Probes Death of Woman Vaccinated With AstraZeneca - Sputnik International, 1920, 17.03.2021
A nurse prepares an AstraZeneca vaccine against COVID-19 at the Alonso Suazo healthcare center in Tegucigalpa, on March 15, 2021.

The Health Ministry said she had suffered an ischemic stroke that transformed into a brain haemorrhage.

The woman was among three people reported to have developed a combination of unusual symptoms — blood clots and a low count of platelets — which may point to an "abnormal activation of the coagulation system, associated with the formation of blood clots in unusual places".

Newsfeed
0
To participate in the discussion
log in or register
loader
Chats
Заголовок открываемого материала